Aspira Womens HealthAWHL -0.18%36 Median PS Value is $3.40 as of Jun. 26, 2026, which is 1519% above its 10-year median of 0.21. GuruFocus rates AWHL with a GF Score™ of 36/100 and a GF Value™ of $0.28 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 86 Medical Diagnostics & Research companies, Aspira Womens Health ranks better than 95.35% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Aspira Womens Health's Median PS Value or its related term are showing as below:
AWHL'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.01 Med: 0.21 Max: 6.42
Current: 0.13
During the past 13 years, the highest Price to Median PS Value of Aspira Womens Health was 6.42. The lowest was 0.01. And the median was 0.21.
AWHL's Price-to-Median-PS-Value is ranked better than 95.35% of 86
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.875
vs AWHL: 0.13
Aspira Womens Health (OTCPK:AWHL) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Aspira Womens Health's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.425
/
3.40
=
0.13
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health Median PS Value Related Terms
Aspira Womens Health Median PS Value Historical Data
* Premium members only.
The historical data trend for Aspira Womens Health's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AWHL vs BIOQ, MBAI, XWEL: Median PS Value Comparison
For the Diagnostics & Research subindustry, Aspira Womens Health's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aspira Womens Health Price-to-Median-PS-Value vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Aspira Womens Health's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Aspira Womens Health's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 15.0442.
Aspira Womens Health's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.226.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aspira Womens Health (AWHL) has a Median PS Value of $3.40 as of Jun. 26, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Aspira Womens Health and its competitors. This is 1519% above median its historical median of 0.21. Over the past decade, Aspira Womens Health's Median PS Value has ranged from 0.01 to 6.42. According to the industry distribution chart, Aspira Womens Health ranks #4 out of 86 companies in the Medical Diagnostics & Research industry, placing it in the top 4.7%.
Is Aspira Womens Health's Median PS Value too high?
Aspira Womens Health's current Median PS Value of $3.40 is 1519% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 6.42. The Medical Diagnostics & Research industry median Median PS Value is 0.88. Aspira Womens Health's value of $3.40 is 288.6% above this industry median. Based on the distribution chart, Aspira Womens Health ranks #4 out of 86 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Aspira Womens Health has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aspira Womens Health's Median PS Value compare to BIOQ and MBAI?
According to the Medical Diagnostics & Research industry distribution chart, Aspira Womens Health ranks #4 out of 86 companies for Median PS Value. This places Aspira Womens Health in the top 5% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.88. Aspira Womens Health's value of $3.40 is 288.6% above this benchmark. Historically, Aspira Womens Health's own Median PS Value has ranged from 0.01 to 6.42 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.88, Aspira Womens Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Diagnostics & Research company?
The median Median PS Value among Medical Diagnostics & Research companies is 0.88, based on 86 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aspira Womens Health's current Median PS Value of $3.40 is 288.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Aspira Womens Health and its competitors. For the Medical Diagnostics & Research industry, the median Median PS Value is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aspira Womens Health's current Median PS Value is $3.40, which is 1519% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspira Womens Health stock overvalued right now?
Based on GuruFocus' analysis, Aspira Womens Health (AWHL) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.28, compared to a current price of $0.43 — trading 51.8% above its estimated fair value. The current Median PS Value is $3.40, which is 1519% above median its 10-year median of 0.21 and 288.6% above the Medical Diagnostics & Research industry median of 0.88. Aspira Womens Health's overall GF Score™ is 36/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Aspira Womens Health (AWHL), the current Median PS Value is $3.40 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aspira Womens Health (AWHL) Overvalued in 2026?
Based on GuruFocus' analysis, Aspira Womens Health stock appears to be overvalued.
The current stock price of $0.43 is trading 51.8% above its estimated GF Value™ of $0.28.
GuruFocus considers Aspira Womens Health to be Significantly Overvalued.
Key valuation signals for AWHL:
Median PS Value: $3.40 (1519% above median its 10-year median of 0.21)
GF Value™: $0.28 vs. price of $0.43 (51.8% above fair value)
Industry Position: 288.6% above the Medical Diagnostics & Research median (#4 of 86)
No single metric tells the full story. See the AWHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its main products include OvaWatch, Ova1Plus, Ova1, and Overa, which are used to assess ovarian cancer risk in women with adnexal masses. The company is also developing EndoCheck for endometriosis. The company views its operations and manages its business in a single operating segment, which is the discovery, development, and commercialization of noninvasive diagnostic tests.
36GF Score
Get the complete analysis for AWHL
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AWHL has been successfully added to your 
